Synopsys, Inc. $SNPS Stock Sold by Danske Bank A S

Danske Bank A S trimmed its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 20.2% in the third quarter, HoldingsChannel.com reports. The firm owned 105,904 shares of the semiconductor company’s stock after selling 26,860 shares during the quarter. Danske Bank A S’s holdings in Synopsys were worth $46,062,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Synopsys in the 2nd quarter worth $747,400,000. Man Group plc acquired a new stake in shares of Synopsys in the second quarter valued at $55,900,000. Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust boosted its stake in Synopsys by 21.3% during the third quarter. Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust now owns 31,144 shares of the semiconductor company’s stock valued at $13,546,000 after buying an additional 5,476 shares in the last quarter. Nykredit A S bought a new position in Synopsys during the second quarter valued at about $23,158,000. Finally, Bank of America Corp DE bought a new position in Synopsys during the second quarter valued at about $539,986,000. 85.47% of the stock is owned by institutional investors.

Trending Headlines about Synopsys

These are some of the SNPS headlines that stood out recently:

  • Positive Sentiment: Synopsys agreed to provide electronic design automation tools for the European Chips Design Platform, which is intended to help startups and midsized firms develop chips for AI, high-performance computing and photonics. The partnership could broaden access to Synopsys’ software, though its financial impact was not specified. Synopsys Joins European Chips Design Platform
  • Negative Sentiment: One report says SNPS had fallen nearly 10% over a week and highlights export-control risks, signaling investor caution despite the company’s exposure to AI-chip development. Synopsys Investment Outlook and Risks
  • Negative Sentiment: ETFs were reported as net sellers of Synopsys shares, disposing of $10.1 million on Nov. 11—a potential source of near-term selling pressure. ETFs Are Net Sellers of Synopsys

Analysts Set New Price Targets

SNPS has been the topic of a number of research analyst reports. Morgan Stanley lifted their target price on Synopsys from $500.00 to $574.00 and gave the stock an “overweight” rating in a report on Tuesday, October 20th. Benchmark reissued a “buy” rating and issued a $570.00 price target on shares of Synopsys in a report on Thursday, August 27th. Needham & Company LLC raised their price objective on shares of Synopsys from $580.00 to $620.00 and gave the company a “buy” rating in a research report on Monday, October 12th. HSBC cut shares of Synopsys from a “buy” rating to a “reduce” rating in a research note on Friday, September 25th. Finally, Wells Fargo & Company boosted their target price on shares of Synopsys from $475.00 to $540.00 and gave the stock an “overweight” rating in a report on Thursday, October 1st. One analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $575.00.

View Our Latest Report on SNPS

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $455.20 on Monday. Synopsys, Inc. has a one year low of $362.55 and a one year high of $539.48. The stock has a fifty day moving average of $445.16 and a 200-day moving average of $441.11. The company has a market capitalization of $87.23 billion, a PE ratio of 80.42, a price-to-earnings-growth ratio of 1.44 and a beta of 1.18. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34.

Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. The business had revenue of $2.48 billion for the quarter, compared to analysts’ expectations of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company’s quarterly revenue was up 42.4% on a year-over-year basis. During the same period in the previous year, the firm posted $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, equities analysts anticipate that Synopsys, Inc. will post 11.01 EPS for the current fiscal year.

Synopsys declared that its board has authorized a stock repurchase program on Monday, October 5th that permits the company to buy back $1 billion in shares. This repurchase authorization permits the semiconductor company to reacquire up to 1.1% of its shares through open market purchases. Share repurchase programs are usually an indication that the company’s leadership believes its stock is undervalued.

Insider Buying and Selling

In related news, insider Janet Lee sold 1,144 shares of Synopsys stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total value of $574,882.88. Following the transaction, the insider owned 16,534 shares of the company’s stock, valued at approximately $8,308,665.68. This trade represents a 6.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Sassine Ghazi sold 14,604 shares of the business’s stock in a transaction dated Thursday, October 15th. The stock was sold at an average price of $462.84, for a total value of $6,759,315.36. Following the sale, the chief executive officer owned 76,865 shares in the company, valued at approximately $35,576,196.60. The trade was a 15.97% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 117,163 shares of company stock valued at $51,366,457. 0.56% of the stock is currently owned by company insiders.

Synopsys Profile

(Free Report)

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.